• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西非囊性纤维化支气管扩张症共识。

Brazilian consensus on non-cystic fibrosis bronchiectasis.

机构信息

. Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas - UNICAMP - Campinas (SP) Brasil.

. Divisão de Pneumologia, Instituto do Coração - InCor - Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.

出版信息

J Bras Pneumol. 2019 Aug 12;45(4):e20190122. doi: 10.1590/1806-3713/e20190122.

DOI:10.1590/1806-3713/e20190122
PMID:31411280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6733718/
Abstract

Bronchiectasis is a condition that has been increasingly diagnosed by chest HRCT. In the literature, bronchiectasis is divided into bronchiectasis secondary to cystic fibrosis and bronchiectasis not associated with cystic fibrosis, which is termed non-cystic fibrosis bronchiectasis. Many causes can lead to the development of bronchiectasis, and patients usually have chronic airway symptoms, recurrent infections, and CT abnormalities consistent with the condition. The first international guideline on the diagnosis and treatment of non-cystic fibrosis bronchiectasis was published in 2010. In Brazil, this is the first review document aimed at systematizing the knowledge that has been accumulated on the subject to date. Because there is insufficient evidence on which to base recommendations for various treatment topics, here the decision was made to prepare an expert consensus document. The Brazilian Thoracic Association Committee on Respiratory Infections summoned 10 pulmonologists with expertise in bronchiectasis in Brazil to conduct a critical assessment of the available scientific evidence and international guidelines, as well as to identify aspects that are relevant to the understanding of the heterogeneity of bronchiectasis and to its diagnostic and therapeutic management. Five broad topics were established (pathophysiology, diagnosis, monitoring of stable patients, treatment of stable patients, and management of exacerbations). After this subdivision, the topics were distributed among the authors, who conducted a nonsystematic review of the literature, giving priority to major publications in the specific areas, including original articles, review articles, and systematic reviews. The authors reviewed and commented on all topics, producing a single final document that was approved by consensus.

摘要

支气管扩张症是一种通过胸部高分辨率 CT 越来越多地诊断出的疾病。在文献中,支气管扩张症分为继发于囊性纤维化的支气管扩张症和不伴囊性纤维化的支气管扩张症,后者称为非囊性纤维化支气管扩张症。许多原因可导致支气管扩张症的发生,患者通常有慢性气道症状、反复感染和与该疾病一致的 CT 异常。2010 年发表了第一份关于非囊性纤维化支气管扩张症的诊断和治疗国际指南。在巴西,这是第一份旨在系统整理迄今为止在该主题上积累的知识的审查文件。由于缺乏各种治疗主题的推荐建议的证据,因此决定编写一份专家共识文件。巴西胸科协会呼吸感染委员会召集了 10 名在巴西具有支气管扩张症专业知识的肺病专家,对现有科学证据和国际指南进行了批判性评估,并确定了与理解支气管扩张症的异质性及其诊断和治疗管理相关的方面。确立了五个广泛的主题(发病机制、诊断、稳定期患者的监测、稳定期患者的治疗以及恶化期的管理)。在这一分组之后,将主题分配给作者,他们对文献进行了非系统性回顾,优先考虑特定领域的主要出版物,包括原始文章、综述文章和系统评价。作者审查并评论了所有主题,生成了一份由共识批准的最终文件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/34dd776d499a/1806-3713-jbpneu-45-04-e20190122-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/c15864545f99/1806-3713-jbpneu-45-04-e20190122-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/d17c8e73c10e/1806-3713-jbpneu-45-04-e20190122-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/cc2f9d4456f2/1806-3713-jbpneu-45-04-e20190122-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/4a0fa9fcc1bd/1806-3713-jbpneu-45-04-e20190122-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/432e34d95909/1806-3713-jbpneu-45-04-e20190122-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/8aacd2beb050/1806-3713-jbpneu-45-04-e20190122-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/34dd776d499a/1806-3713-jbpneu-45-04-e20190122-gf7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/c15864545f99/1806-3713-jbpneu-45-04-e20190122-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/d17c8e73c10e/1806-3713-jbpneu-45-04-e20190122-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/cc2f9d4456f2/1806-3713-jbpneu-45-04-e20190122-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/4a0fa9fcc1bd/1806-3713-jbpneu-45-04-e20190122-gf4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/432e34d95909/1806-3713-jbpneu-45-04-e20190122-gf5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/8aacd2beb050/1806-3713-jbpneu-45-04-e20190122-gf6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9701/6733718/34dd776d499a/1806-3713-jbpneu-45-04-e20190122-gf7.jpg

相似文献

1
Brazilian consensus on non-cystic fibrosis bronchiectasis.巴西非囊性纤维化支气管扩张症共识。
J Bras Pneumol. 2019 Aug 12;45(4):e20190122. doi: 10.1590/1806-3713/e20190122.
2
Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症的感染预防和慢性病管理。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620905272. doi: 10.1177/1753466620905272.
3
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
4
Non-CF bronchiectasis: Orphan disease no longer.非囊性纤维化支气管扩张症:不再是孤儿病。
Respir Med. 2020 May;166:105940. doi: 10.1016/j.rmed.2020.105940. Epub 2020 Mar 27.
5
Interventions for bronchiectasis: an overview of Cochrane systematic reviews.支气管扩张症的干预措施:Cochrane系统评价概述
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD010337. doi: 10.1002/14651858.CD010337.pub2.
6
Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis.英国胸科学会非囊性纤维化支气管扩张管理指南的初级保健总结
Prim Care Respir J. 2011 Jun;20(2):135-40. doi: 10.4104/pcrj.2011.00007.
7
HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis.高分辨率CT(HRCT)显示的肺部异常并非支气管扩张症运动受限的替代指标。
Eur Respir J. 2004 Oct;24(4):538-44. doi: 10.1183/09031936.04.00142903.
8
Bronchiectasis: causes and management.支气管扩张症:病因与管理
Indian J Pediatr. 2000 Feb;67(2):133-9. doi: 10.1007/BF02726189.
9
Upper airway 2: Bronchiectasis, cystic fibrosis and sinusitis.上呼吸道 2:支气管扩张症、囊性纤维化和鼻窦炎。
Thorax. 2009 Dec;64(12):1096-101. doi: 10.1136/thx.2008.112870.
10
Self-management for bronchiectasis.支气管扩张症的自我管理
Cochrane Database Syst Rev. 2018 Feb 7;2(2):CD012528. doi: 10.1002/14651858.CD012528.pub2.

引用本文的文献

1
Effect of Dual Bronchodilation on the Exercise Capacity of Individuals With Non-Cystic Fibrosis Bronchiectasis: Protocol for a Randomized Controlled Double-Blind Crossover Study.双重支气管扩张对非囊性纤维化支气管扩张症患者运动能力的影响:一项随机对照双盲交叉研究方案
JMIR Res Protoc. 2025 Jul 28;14:e68582. doi: 10.2196/68582.
2
Incidence rate, clinical profile, and outcomes of COVID-19 in adults with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症成人患者中新冠病毒病的发病率、临床特征及预后
J Bras Pneumol. 2025 Jan 27;51(1):e20240258. doi: 10.36416/1806-3756/e20240258.
3
Early and late outcomes of video thoracoscopic versus open approach for bronchiectasis lung resections.

本文引用的文献

1
Validation of the Incremental Shuttle Walk Test as a Clinical End Point in Bronchiectasis.递增式 Shuttle 步行试验在支气管扩张症中的临床终点验证。
Chest. 2018 Dec;154(6):1321-1329. doi: 10.1016/j.chest.2018.09.019. Epub 2018 Oct 6.
2
Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis.非囊性纤维化支气管扩张症患者恶化导致的住院费用。
Respiration. 2018;96(5):406-416. doi: 10.1159/000489935. Epub 2018 Jul 11.
3
Outcomes of lung transplantation in adults with bronchiectasis.支气管扩张症成人肺移植的结果。
视频胸腔镜与开胸手术治疗支气管扩张症肺切除的早期和晚期结果。
Rev Col Bras Cir. 2024 Sep 6;51:e20243748. doi: 10.1590/0100-6991e-20243748-en. eCollection 2024.
4
Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症的比较微生物组分析。
Respir Res. 2024 May 18;25(1):211. doi: 10.1186/s12931-024-02835-w.
5
Do Causes Influence Functional Aspects and Quality of Life in Patients with Nonfibrocystic Bronchiectasis?病因是否会影响非纤维囊性支气管扩张症患者的功能状况和生活质量?
Pulm Med. 2024 Apr 15;2024:3446536. doi: 10.1155/2024/3446536. eCollection 2024.
6
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease.巴西胸科协会关于肺结核后肺部疾病管理的建议。
J Bras Pneumol. 2024 Jan 5;49(6):e20230269. doi: 10.36416/1806-3756/e20230269. eCollection 2024.
7
Global survey of physician testing practices for nontuberculous mycobacteria.非结核分枝杆菌医师检测实践的全球调查。
ERJ Open Res. 2023 May 2;9(3). doi: 10.1183/23120541.00737-2022. eCollection 2023 Jul.
8
Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by : A Narrative Review of Current Evidence.吸入用硫酸多粘菌素甲磺酸钠在支气管扩张合并感染患者治疗中的应用:当前证据的叙述性综述
Infect Drug Resist. 2022 Dec 14;15:7271-7292. doi: 10.2147/IDR.S318173. eCollection 2022.
9
The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial.N-乙酰半胱氨酸对非囊性纤维化支气管扩张症(NINCFB)患者的影响:一项多中心、双盲、随机、安慰剂对照试验的研究方案。
BMC Pulm Med. 2022 Nov 7;22(1):401. doi: 10.1186/s12890-022-02202-9.
10
Mutagenic damage among bronchiectasis patients attending in the pulmonology sector of a hospital in southern Brazil.巴西南部一家医院肺病科就诊的支气管扩张症患者中的诱变损伤。
Rev Assoc Med Bras (1992). 2022 Sep;68(9):1191-1198. doi: 10.1590/1806-9282.20220178.
BMC Pulm Med. 2018 May 22;18(1):82. doi: 10.1186/s12890-018-0634-4.
4
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.支气管扩张症的病因、流行病学和微生物学的地域差异。
BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0.
5
Inhaled corticosteroids for bronchiectasis.支气管扩张症的吸入性糖皮质激素治疗
Cochrane Database Syst Rev. 2018 May 16;5(5):CD000996. doi: 10.1002/14651858.CD000996.pub3.
6
A Prospective Trial of Nebulized Amikacin in the Treatment of Bronchiectasis Exacerbation.雾化阿米卡星治疗支气管扩张症加重的前瞻性试验。
Respiration. 2018;95(5):327-333. doi: 10.1159/000486134. Epub 2018 Mar 27.
7
Macrolide antibiotics for bronchiectasis.用于支气管扩张症的大环内酯类抗生素
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012406. doi: 10.1002/14651858.CD012406.pub2.
8
The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis.FACED和E-FACED评分对支气管扩张症患者死亡率的年度预测能力。
ERJ Open Res. 2018 Mar 6;4(1). doi: 10.1183/23120541.00139-2017. eCollection 2018 Jan.
9
The independent contribution of infection to long-term clinical outcomes in bronchiectasis.感染对支气管扩张长期临床结局的独立影响。
Eur Respir J. 2018 Jan 31;51(2). doi: 10.1183/13993003.01953-2017. Print 2018 Feb.
10
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.RESPIRE 2 研究:一项比较环丙沙星干粉吸入剂与安慰剂治疗非囊性纤维化支气管扩张症的 III 期、安慰剂对照、随机临床试验。
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.02053-2017. Print 2018 Jan.